{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:02:54Z","timestamp":1793084574957,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.japh.2026.103055","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:25:03Z","timestamp":1771979103000},"page":"103055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of clinical pharmacists with extended prescribing rights in a hemodialysis unit"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3600-1307","authenticated-orcid":false,"given":"Astrid","family":"Bacle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4609-4762","authenticated-orcid":false,"given":"Victor","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2026.103055_bib1","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: the CaReMe CKD study","volume":"20","author":"Sundstr\u00f6m","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.japh.2026.103055_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4852","article-title":"Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system","volume":"1","author":"Tonelli","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.ajkd.2005.07.001","article-title":"Medication-Related problems in ambulatory hemodialysis patients: a pooled analysis","volume":"46","author":"Manley","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.japh.2026.103055_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.18549\/PharmPract.2016.03.785","article-title":"A pharmacy-based medication reconciliation and review program in hemodialysis patients: a prospective study","volume":"14","author":"Patricia","year":"2016","journal-title":"Pharm Pract (Granada)"},{"issue":"6","key":"10.1016\/j.japh.2026.103055_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4212\/cjhp.v70i6.1719","article-title":"Ambulatory medication reconciliation in dialysis patients: benefits and community practitioners' perspectives","volume":"70","author":"Wilson","year":"2017","journal-title":"Can J Hosp Pharm"},{"issue":"11","key":"10.1016\/j.japh.2026.103055_bib6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2215\/CJN.01420213","article-title":"Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach","volume":"8","author":"Pai","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/ejhpharm-2022-003625","article-title":"A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study","volume":"31","author":"Lhermitte","year":"2024","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/gfr287","article-title":"Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review","volume":"27","author":"Salgado","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.japh.2026.103055_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"10.1016\/j.japh.2026.103055_bib11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/phar.1438","article-title":"Standards of practice for clinical pharmacists","volume":"34","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.japh.2026.103055_bib12","first-page":"830","article-title":"Acceptance of pharmacists' suggestions by prescribers: a literature review","volume":"25","author":"Klopfer","year":"1990","journal-title":"Hosp Pharm"},{"issue":"5","key":"10.1016\/j.japh.2026.103055_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1331\/154434503322452256","article-title":"Do community pharmacists influence prescribing?","volume":"43","author":"Carroll","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.japh.2026.103055_bib14","doi-asserted-by":"crossref","first-page":"e13827","DOI":"10.1111\/ijcp.13827","article-title":"Pharmacist non-medical prescribing in primary care. A systematic review of views, opinions, and attitudes","volume":"75","author":"Mills","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jppr.70006","article-title":"Renal clinical pharmacy services and outcomes for patients on dialysis: a scoping review","volume":"55","author":"Livori","year":"2025","journal-title":"Pharm Pract Res"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3821\/1913-701X-145.1.7","article-title":"Legislative change in Quebec gives pharmacists expanded authorities","volume":"145","author":"Lynas","year":"2012","journal-title":"Can Pharm J (Ott)"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11096-006-9027-5","article-title":"Validation of an instrument for the documentation of clinical pharmacists' interventions","volume":"28","author":"Allenet","year":"2006","journal-title":"Pharm World Sci"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ejhpharm-2020-002642","article-title":"CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions","volume":"28","author":"Vo","year":"2021","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2369-12-35","article-title":"Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review","volume":"12","author":"Stemer","year":"2011","journal-title":"BMC Nephrol"},{"issue":"1297","key":"10.1016\/j.japh.2026.103055_bib22","first-page":"25","article-title":"Implementation of a pharmacist medication review clinic for haemodialysis patients","volume":"122","author":"Mirkov","year":"2009","journal-title":"N Z Med J"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40780-024-00340-2","article-title":"Medication reconciliation by pharmacists for pre-admission patients improves patient safety","volume":"10","author":"Yamada","year":"2024","journal-title":"J Pharm Health Care Sci"},{"issue":"9","key":"10.1016\/j.japh.2026.103055_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24672","article-title":"Effect of medication reconciliation at hospital admission on 30-day returns to hospital: a randomized clinical trial","volume":"4","author":"Ceschi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.japh.2026.103055_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.811289","article-title":"Acceptance factors for in-hospital pharmacist interventions in daily practice: a retrospective study","volume":"13","author":"Durand","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.japh.2026.103055_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/jcpt.13017","article-title":"Evaluation of drug-related problems and subsequent clinical pharmacists' interventions at a Swiss university hospital","volume":"44","author":"Reinau","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.japh.2026.103055_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejim.2018.08.017","article-title":"Assessment of the clinical relevance of pharmacists' interventions performed during medication review in a rheumatology ward","volume":"59","author":"Yailian","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jcpt.12214","article-title":"Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP\u00a9 website observatory","volume":"40","author":"Bedouch","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.japh.2026.103055_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.japh.2026.103055_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2015.05.012","article-title":"Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist","volume":"26","author":"Guignard","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s11096-019-00832-4","article-title":"Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand","volume":"41","author":"Semcharoen","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.japh.2026.103055_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/phar.1578","article-title":"Nationwide evaluation of day-to-day clinical pharmacists' interventions in German hospitals","volume":"35","author":"Langebrake","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.japh.2026.103055_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bcp.15301","article-title":"Impact of pharmacist intervention in reducing vancomycin-associated acute kidney injury: a systematic review and meta-analysis","volume":"89","author":"Kunming","year":"2023","journal-title":"Br J Clin Pharma"},{"issue":"6","key":"10.1016\/j.japh.2026.103055_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/ejhpharm-2016-001165","article-title":"Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions","volume":"24","author":"Falconer","year":"2017","journal-title":"Eur J Hosp Pharm"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319126000403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:37:46Z","timestamp":1780947466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319126000403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1544319126000403"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2026.103055","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of clinical pharmacists with extended prescribing rights in a hemodialysis unit","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2026.103055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103055"}}